Literature DB >> 22378185

Charged behaviour from neutral ligands: synthesis and properties of N-heterocyclic pseudo-amides.

Robert J Thatcher1, David G Johnson, John M Slattery, Richard E Douthwaite.   

Abstract

Deprotonation of the 1-isopropyl-3-(phenylamino)pyridin-1-ium iodide gives the corresponding neutral betaine, which is formalised as a pyridinium-amido ligand when coordinated to a metal. Spectroscopic, structural and theoretical methods have been used to investigate the metal-ligand bonding, ligand dynamics and electron distribution. Collectively, the data show that the ligand can be characterised as a pseudo-amide and is a strong donor akin to alkyl phosphines and N-heterocyclic carbenes. Furthermore, rotation about both N substituent C-N bonds occurs, which is in contrast to the two alternative pyridinium positional isomers that exhibit neutral resonance structures. For comparison, compounds and complexes derived from norharman were prepared, which contain an additional C-C bond supporting conjugation and the accessibility of a neutral resonance structure. Notwithstanding the formal neutral structure, norharman-derived ligands are comparably strong donors, and have the additional advantage of exhibiting stability to dioxygen and water.
Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Year:  2012        PMID: 22378185     DOI: 10.1002/chem.201103319

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  2 in total

1.  Crystal structure of di-μ-iodido-bis-{[1,3-bis-(2,6-diiso-propyl-phen-yl)imidazol-2-yl-idene]lithium}.

Authors:  Hui-Da Wan; Jian-Quan Hong
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2015-05-28

2.  Mesoionic Imines (MIIs): Strong Donors and Versatile Ligands for Transition Metals and Main Group Substrates.

Authors:  Richard Rudolf; Nicolás I Neuman; Robert R M Walter; Mark R Ringenberg; Biprajit Sarkar
Journal:  Angew Chem Int Ed Engl       Date:  2022-04-19       Impact factor: 16.823

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.